Physician profile
Yuhua Xiao
NPI 1467861237
$2,007.16
in general payments reported to CMS, 2019-2025
18 companies · $848 in 2025
The $848 reported for 2025 was more than what 82% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.43 · 2022: $68.59 · 2023: $485 · 2024: $582 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543 · Education: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.35 |
| Education | $370.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $646.63 | 2023-2025 | Cresemba, Xospata |
| Incyte Corporation | $214.62 | 2022-2025 | Jakafi, Niktimvo |
| Astrazeneca Pharmaceuticals Lp | $214.08 | 2021-2025 | Calquence |
| Lilly USA, LLC | $168.53 | 2024-2025 | Jaypirca |
| Janssen Biotech, INC. | $123.55 | 2022-2024 | Imbruvica |
| Celgene Corporation | $110.84 | 2022-2025 | Reblozyl |
| Sobi, INC | $65.49 | 2025 | |
| Taiho Oncology, INC. | $64.05 | 2023-2025 | |
| Syndax Pharmaceuticals, INC. | $60.98 | 2025 | |
| Beigene USA, INC. | $59.41 | 2024 | Brukinsa |
| Abbvie INC. | $57.91 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $54.38 | 2024-2025 | |
| Rigel Pharmaceuticals, INC. | $30.95 | 2023 | Tavalisse, Rezlidhia |
| Glaxosmithkline, LLC. | $30.06 | 2024 | Ojjaara |
| Amgen INC. | $28.31 | 2023 | Blincyto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cti Biopharma Corp. | $27.00 | 2023 | Vonjo |
| Pharmaessentia USA Corporation | $25.39 | 2023 | Besremi |
| Servier Pharmaceuticals LLC | $24.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuhua Xiao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.